
Discover Viatris
Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results

Discover Viatris
U.S. FDA Accepts Viatris Supplemental New Drug Application for Investigational Presbyopia Treatment, Sets PDUFA Goal Date

Discover Viatris
Viatris Appoints Matthew J. Maletta as Chief Legal Officer

Discover Viatris







